Paul Chaplin, Bavarian Nordic president and CEO

With mon­key­pox cas­es ris­ing, one Eu­ro­pean coun­try is lock­ing down a small­pox vac­cine con­tract

As the glob­al num­ber of con­firmed and sus­pect­ed mon­key­pox cas­es con­tin­ues to slow­ly climb, one coun­try is try­ing to get a head start on po­ten­tial vac­cine stock­ing.

Bavar­i­an Nordic signed a con­tract with an undis­closed Eu­ro­pean na­tion to sup­ply its small­pox vac­cine in re­sponse to new cas­es this month, the com­pa­ny an­nounced Thurs­day morn­ing. The con­ti­nent saw its first mon­key­pox case con­firmed about two weeks ago, with both the UK and Por­tu­gal see­ing cas­es, ac­cord­ing to the Wash­ing­ton Post.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.